This review provides an overview of the mechanisms, diagnosis, and evolving therapeutic strategies for viral myocarditis.
Answers are grounded in this paper and cite their sources.
Synthesizes mechanisms for clinicians facing viral myocarditis; leaves open prospective trials to validate emerging therapies.
Viral myocarditis remains a prominent infectious-inflammatory disease for patients throughout the lifespan. The condition presents several challenges including varied modes of clinical presentation, a range of timepoints when patients come to attention, a diversity of approaches to diagnosis, a spectrum of clinical courses, and unsettled perspectives on therapeutics in different patient settings and in the face of different viral pathogens. In this review, we examine current knowledge about viral heart disease and especially provide information on evolving understanding of mechanisms of disease and efforts by investigators to identify and evaluate potential therapeutic avenues for intervention.
No takes yet. Share an insight, caveat, or question.
Fung et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: